1.. Background {#s6}
==============

Schizophrenia is associated with impaired social cognition, which in turn is associated with reduced functional outcomes and quality of life.\[[@B1]\] Social cognition broadly refers to the processes involved with decoding social and emotive information, including perspective, Theory of Mind (ToM), affect perception and regulation, and causal attribution.\[[@B2]\] Impairments with affect recognition and processing are considered especially important in affecting other social cognition domains.\[[@B3]\] Measurements of affect recognition are strong predictors of social performance and long-term functional outcomes for people with schizophrenia.\[[@B4]\]

One meta-analysis concludes that impairment in social cognition is a better predictor of long-term outcomes in schizophrenia than impairments in neurocognition.\[[@B5]\] There is also good evidence to suggest that social cognition training is an effective method of improving the social, psychological, and occupational outcomes for schizophrenia. A meta-analysis by Grynszpan and colleagues\[[@B6]\] found a medium effect size (0.64) for improvements in social cognition after computer-based remediation. Further, a recent review of 23 studies examining the efficacy of programs targeting facial affect recognition (FAR) deficits in schizophrenia concluded that they are efficacious in improving both FAR performance and functional status.\[[@B7]\] There is also evidence to suggest that social cognition remediation may be neuro-protective for individuals with schizophrenia. A two-year randomized control trial by Eack\[[@B8]\] found that participants who received Cognitive Enhancement Therapy --- which includes social cognition tasks --- had significantly greater grey matter preservation in the left hippocampus, parahippocampal gyrus, and the fusiform gyrus compared to participants who received enriched supportive therapy (who showed increased grey matter preservation in the left amygdala). Results such as these support the efficacy of cognitive remediation as an additional therapeutic option in schizophrenia.

Of all the processes included as components of social cognition, facial affect recognition is one of the best researched. Facial affect recognition is largely uninfluenced by medication but can be improved by training and remediation.\[[@B7], [@B9], [@B10]\] Facial affect recognition training --- generally involving being asked to identify images of faces displaying emotion --- has been shown to be effective for both male and female inpatients and outpatients with schizophrenia or schizoaffective disorder who are taking typical or atypical antipsychotic medication.\[[@B9], [@B10], [@B11], [@B12]\]

In addition to the more recent support for social cognitive remediation, neurocognitive remediation is well established as an efficacious intervention for improving cognition in schizophrenia.\[[@B13], [@B14]\] Remediation programs typically require highly trained clinicians, so they are costly in terms of time and funding and, thus, may be difficult to justify in routine practice. However, cognitive remediation programs have been shown to be cost-effective in the short-term, \[[@B15]\] and may also reduce long-term costs when the benefits of improved social and occupational functioning are sustained over time.\[[@B16]\]

Schizophrenia presents a unique and significant global public health issue, and China is no exception.\[[@B17]\] The majority of mental health treatment in China is administered by psychiatrists and psychiatric nurses in specialized psychiatric hospitals, most of which are located in urban centers. This is primarily due to the relatively small number of psychologists, social workers, and occupational therapists who could provide psychosocial support and to the limited training of community-based medical practitioners about the recognition and management of mental disorders.\[[@B18]\]

We have previously demonstrated the efficacy of a pilot program for the remediation of cognitive deficits in schizophrenia in China using a simple, cross-cultural computer-based drill training program.\[[@B19]\] This previous study was implemented in an inpatient setting and resulted in modest improvements on a test of attention. Moreover, there were additional and somewhat unexpected findings of improvements in social functioning and clinical symptoms in the intervention group. Given recent evidence of the importance of remediation of social functioning deficits, we sought to replicate our earlier study using an enhanced computerized remediation program that included facial affect recognition training. Further, we also wanted to explore the efficacy of the program in an outpatient setting. We aimed to assess the suitability of this program by conducting a six-week trial with a sample of outpatients in China. Based on our previous study, we hypothesized that the intervention group would demonstrate significant improvement in attention and, secondarily, that their facial affect recognition scores would improve after training. Based on the findings from the original study, we also hypothesized that the intervention group would improve on a measure of social functioning. Due to the relatively short duration of the intervention (6 weeks), significant changes to clinical symptoms were not expected.

2.. Methods {#s7}
===========

The study, which was conducted at the Shanghai Mental Health Center, received institutional ethics approval. All participants provided written informed consent.

2.1. Participants {#s7a}
=================

As shown in [Figure 1](#Figure1){ref-type="fig"}, participants were male outpatients at the Shanghai Mental Health Center with a current DSM-IV diagnosis of schizophrenia as determined by the treating clinician based on a clinical interview and referral to the medical records. Potential participants had to be 18-55 years of age and not have a co-morbid substance use disorder. A total of 40 male outpatients were enrolled: 20 were long-term (\>12 months) attendees of the hospital's rehabilitation center (the intervention group), and 20 were outpatients at the hospital not attending the rehabilitation center who responded to flyers advertising the study (the control group). All enrolled patients were clinically stable, regularly taking stable doses of antipsychotic medication, and receiving regular follow-up in the outpatient department. Patients in the intervention group also received a 6-week computerized intervention that included both cognitive training and facial affect recognition (FAR) training (described below). All 40 participants completed baseline and 6-week follow-up assessments of clinical, cognitive, and social functioning.

![Figure 1. Flowchart of the study](sap-27-05-296-g002){#Figure1}

2.2. Intervention {#s7b}
=================

A description of the development and content of the cognitive remediation Computerized Drill Training (CDT) program administered to the intervention group has been reported previously.\[[@B19]\] It basically involves five simple, repetitive drill training exercises in arithmetic, number lists, pair matching, spatial working memory, and word lists.

The computerized facial affect recognition training module developed for this study utilized posed photographs from the Nanyang Technological University Asian Face Emotion Database, developed by Wong and Cho\[[@B20]\] at the Nanyang Technological University (NTU) in Singapore. This database contains facial photographs of 153 individuals of Asian heritage aged between 20 and 29 years who posed seven different facial expressions (neutral, angry, happy, sad, surprised, afraid, and disgusted) and consented to having these images stored on the database. (There are no reliability estimates for the emotional classification of these photographs yet available, but the database has been used in at least one published study of cross-cultural FAR.\[[@B21]\]) In this study we selected 96 photographs of individuals of Chinese ethnicity from the database that we considered best represented the six emotions (16 photographs of each of the six non-neutral emotions). The training sessions employed 72 photographs of 36 different individuals (12 photographs of each emotion) and the pre-post testing of FAR employed the remaining 24 photographs of 24 different individuals (4 photographs of each emotion). Six individuals appeared in both the training and testing components, but they displayed different emotions in the testing set than they did in the training set.

During the FAR training, the 72 different photographs were displayed in black and white and centered on a computer screen in random order with an equal mix of male and female faces. When a face appeared on the computer screen, participants were required to select which of the six possible emotion labels (happy, sad, afraid, angry, surprised, or disgusted) best described the emotion displayed in the stimulus face. Responses were not timed. In the event of an incorrect response, the correct label subsequently appeared on the screen. Each of the 72 photographs only appeared once during a training session. The FAR component of the computerized training took about 10 minutes to complete.

In this study FAR training was combined with CDT; both separate modules were completed on the same computer and the order of presenting the two modules was randomized. It typically took 45-60 minutes to complete both modules. The training was done in group sessions monitored by two trained psychiatric nurses. Following an initial training session, participants were expected to complete at least 12 computerbased training sessions over a 6-week period. The mean (sd) number of CDT sessions completed by the 20 intervention-group patients was 12.85 (0.59) and the mean number of FAR training sessions completed was 12.60 (0.50). (The number of CDT and FAR sessions completed is slightly different because of technical difficulties during some training sessions.) As all participants in the intervention group completed at least 12 sessions, the 12th training session was considered the 'final' session in the analysis.

2.3. Assessments {#s7c}
================

In order to allow comparison with our previous inpatient study, we used the same outcome measures employed in the earlier study\[[@B19]\] and added pre- and post-measures of facial affect recognition (FAR) to assess the effectiveness of the FAR component that was added to the cognitive remedial training package. Pre and post assessments of intervention and control group participants were conducted individually by either one of the trained psychiatric nurses or by one of the authors (LP). These evaluators were not blind to the group assignment of the individuals they assessed.

2.3.1. Clinical symptoms and social functioning {#s7ca}
===============================================

Participants in both groups were rated on three clinical scales measuring symptoms, global functioning, and social functioning. A Chinese version of the Positive and Negative Syndrome Scales (PANSS)\[[@B22]\] was administered to all participants at baseline and at the end of the trial by an experienced psychiatrist (LP) trained in the consensus rating of this measure.

The Clinical Global Impression Scale (CGI) is a well recognized tool of global functioning that yields three measures; severity of illness, global improvement, and an efficacy index. It has been widely used with Chinese individuals in Taiwan\[[@B23], [@B24]\] and in mainland China.\[[@B25], [@B26]\] The Severity of Illness item in the scale requires the clinicians to rate the severity of illness at the time of assessment on a 7-point scale from 1 (normal, not at all ill) to 7 (among the most severely ill). Thus, a lower score indicates better functioning. For this study, only the Severity of Illness item of the CGI was used.

The Personal and Social Performance Scale (PSP)\[[@B27]\] is a 100-point rating scale that assesses four domains of social functioning: a) socially useful activities, including work and study; b) personal and social relationships; c) self-care, and; d) disturbing and aggressive behaviors. The total score is divided into three levels: 71-100 is classified as 'mild difficulties'; 31-70 as 'disabled', and 0-30 as 'poor' (i.e., requiring intensive support or supervision). A Chinese version of the PSP\[[@B28]\] has demonstrated good internal consistency (Cronbach's alpha=0.84), test-retest reliability (intra-class correlation coefficient=0.95) and inter-rater reliability (kappa=0.82), as well as robust construct validity.

2.3.2. Neurocognitive assessment {#s7cb}
================================

The brief cognitive assessments included in this study, assessed by trained psychiatric nurses, included a measure of verbal working memory and a measure of verbal memory and learning. A Chinese version of the letter-number sequencing task (LNST)\[[@B29]\] was used to assess verbal working memory; the total score was used as the variable of interest. The verbal memory task employed was Form B of the Hong Kong List Learning Test (HKLLT),\[[@B30]\] a Chinese verbal learning and memory test that has been well validated in a variety of populations including individuals with schizophrenia.\[[@B31]\] Form B of the HKLLT yields information across four trials in a blocked condition where the words are semantically related; the total score for the test was used as the memory variable in this analysis.

2.3.3. Social cognitive assessment {#s7cc}
==================================

Twenty-four photographs (4 for each of six emotions) from the NTU Asian Face Emotion Database (see above) were used at baseline and at the end of the 6-week trial to assess pre-post changes in facial affect recognition (FAR) in both groups. (These were different from the 72 photographs used in the training sessions with the intervention group.) Participants were shown the black and white photographs one at a time in a booklet and asked to circle the emotion that they thought the face was making. The number of correct assignments for each of the six emotions (scored 0-4) and for all 24 pictures (scored 0-24) was recorded for each respondent.

3.. Data Analysis {#s8}
=================

Group differences in demographic characteristics and in baseline clinical, cognitive, and FAR variables were assessed using analysis of variance (ANOVA). At the end of the 6-week trial, within-group changes in clinical, cognitive, and FAR outcomes were assessed using paired sample t-tests, \[[@B33]\] and between-group differences in the changes over the 6 weeks were assessed using analysis of co-variance (ANCOVA) which adjusted for the baseline values of the outcome variables. In the ANCOVA for each outcome variable, Levene's tests were all non-significant (*p*\>0.05), indicating that the assumption of the equality of variances was met.

To assess the magnitude of any treatment effects and the magnitude of changes in the treatment-as-usual control group, we calculated group-specific standardized effect sizes for each variable of interest by dividing the difference of the pre-trial and post-trial means (for each group) by the standard deviation of the difference scores.\[[@B34]\] To examine any learning across the 12 sessions of the training program in the intervention group, mean performance at each session was charted and paired sample t-tests assessed differences between the first and last session for each of the cognitive and FAR component tests.

4.. Results {#s9}
===========

All 40 enrolled participants completed both the baseline assessment and the 6-week follow-up assessment. As shown in [Table 1](#Table1){ref-type="table"}, there were no significant differences between groups in age, educational attainment, duration of illness, or daily chlorpromazine-equivalent\[[@B32]\] dosage of antipsychotic medication.

###### 

Table 1. Characteristics of the sample

Table 1.

  -------------------------------------------------------------------------------------------------------
  characteristic                  intervention group\   control group\   statistic
                                  (n=20)\               (n=20)\          
                                  mean (sd)             mean (sd)        
  ------------------------------- --------------------- ---------------- --------------------------------
  age in years                    38.3 (12.5)           37.0 (8.1)       *F*~(1,\ 38)~=0.153; *p*=0.698

  years of education              11.6 (2.5)            11.7 (2.1)       *F*~(1,\ 34)~=0.025; *p*=0.876

  years duration of illness       12.7 (5.6)            13.2 (8.6)       *F*~(1,\ 37)~=0.181; *p*=0.673

  chlorpromazine-equivalent\      250 (157)             226 (75)         *F*~(1,\ 38)~=0.385; *p*=0.538
  dosage of medication (mg/day)                                          
  -------------------------------------------------------------------------------------------------------

4.1. Clinical, social, and neurocognitive results {#s9a}
=================================================

The results of the clinical, social, and cognitive measures are shown in [Table 2](#Table2){ref-type="table"}. At baseline the intervention group had significantly more severe positive symptoms of psychosis than the control group (as assessed by the PANSS positive symptom subscale). Both of the groups showed a small, but statistically significant decrease in the PANSS negative symptom subscale score over the 6-week trial. The intervention group also had a statistically significant decrease in the PANSS positive and general psychopathology subscale scores (see [Table 2](#Table2){ref-type="table"}). However, at the end of the trial there were no significant differences in the clinical measures between the groups and there were no significant differences in the magnitude of change in these measures between the two groups.

###### 

Table 2. Result of the clinical, social functioning, and neurocognitive measures before and after the 6-week trial in the intervention and control groups

Table 2.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Scale:\                                                                                                                time                       intervention\        control\            group\
  subscale                                                                                                                                          group\               group\              comparison*^a^*
                                                                                                                                                    (n=20)               (n=20)              
  ---------------------------------------------------------------------------------------------------------------------- -------------------------- -------------------- ------------------- -----------------------------------
  Positive and Negative Symptom Scale:\                                                                                  baseline, mean (sd)\       16.15 (1.92)\        14.40 (1.98)\       *F*~(1,\ 38)~=8.01; *p*=0.007\
  positive symptoms                                                                                                      6 weeks, mean (sd)\        15.55 (1.76)\        14.45 (2.11)\       *F*~(1,\ 37)~=0.31; *p*=0.576\
                                                                                                                         paired t-test (p-value)\   **2.26 (0.036)**\    -0.16 (0.878)\      \
                                                                                                                         effect size                0.51                 0.03                

  Positive and Negative Symptom Scale:\                                                                                  baseline, mean (sd)\       23.65 (2.53)\        22.40 (2.01)\       *F*~(1,\ 38)~=2.98; *p*=0.093\
  negative symptoms                                                                                                      6 weeks, mean (sd)\        22.25 (1.71)\        21.85 (1.56)\       *F*~(1,\ 37)~=0.91;*p*=0.764
                                                                                                                         paired t-test (p-value)\   **2.52 (0.021)**\    **2.77 (0.012)**\   
                                                                                                                         effect size                0.56                 0.62                

  Positive and Negative Symptom Scale:\                                                                                  baseline, mean (sd)\       13.4 (1.14)\         13.40 (1.04)\       *F*~(1,\ 38)~=0.00;*p*=1.000\
  general psychopathology                                                                                                6 weeks, mean (sd)\        12.8 (1.00)\         12.95 (1.35)\       *F*~(1,\ 37)~=0.27; *p*=0.603
                                                                                                                         paired t-test (p-value)\   **3.26 (0.004)**\    1.91 (0.070)\       
                                                                                                                         effect size                0.73                 0.42                

  Clinical Global Impression Scale:\                                                                                     baseline, mean (sd)\       3.70 (0.73)\         3.45 (0.60)\        *F*~(1,\ 38)~=1.39; *p*=0.247\
  severity of illness measure                                                                                            6 weeks, mean (sd)\        3.55 (0.60)\         3.50 (0.60)\        *F*~(1,\ 37)~=0.57; *p*=0.453
                                                                                                                         paired t-test (p-value)\   1.14 (0.267)\        -0.57 (0.577)\      
                                                                                                                         effect size                0.25                 0.05                

  Personal and Social Performance Scale                                                                                  baseline, mean (sd)\       55.95 (5.77)\        54.70 (5.94)\       *F*~(1,\ 38)~=0.45; *p*=0.504\
                                                                                                                         6 weeks, mean (sd)\        58.63 (6.13)\        55.85 (7.53)\       ***F*~(1,\ 37)~=1.85; *p*=0.018**
                                                                                                                         paired t-test (p-value)\   **-3.06 (0.006)**\   -1.71 (0.104)\      
                                                                                                                         effect size                0.68                 0.38                

  Hong Kong List Learning Test                                                                                           baseline, mean (sd)\       18.70 (6.60)\        22.95 (5.74)\       *F*~(1,\ 38)~=4.71; *p*=0.036\
                                                                                                                         6 weeks, mean (sd)\        15.85 (3.91)\        20.00 (6.71)\       *F*~(1,\ 37)~=2.81; *p*=0.102
                                                                                                                         paired t-test (p-value)\   **2.39 (0.027)**\    1.62 (0.121)\       
                                                                                                                         effect size                0.53                 0.36                

  Letter-Number Sequencing Tasks                                                                                         baseline, mean (sd)\       9.90 (4.47)\         9.95 (5.45)\        *F*~(1,\ 38)~=0.00; *p*=0.975\
                                                                                                                         6 weeks, mean (sd)\        10.10 (3.50)\        10.85 (7.08)\       *F*~(1,\ 37)~=0.20; *p*=0.654
                                                                                                                         paired t-test (p-value)\   -0.18 (0.863)\       -0.67 (0.512)\      
                                                                                                                         effect size                0.03                 0.14                

  ^a^ The F-value at 6 weeks is for an analysis of covariance (ANCOVA) that uses the result at baseline as a covariate                                                                       
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Based on the results of the single measure of overall social functioning employed in the study (PSP), there were no significant differences between groups at baseline, but the intervention group experienced a much larger (statistically significant) improvement in social functioning than the control group over the 6-week trial. By the end of the trial, social functioning was significantly better in the intervention group than in the control group. However, at the end of the study the proportion of subjects in the three functional categories in the intervention group (0.0% poor, 97.6% disabled, 2.4% mild difficulties) was not significantly different from the corresponding proportions in the control group (0.0% poor, 100.0% disabled, and 0.0% mild difficulties) (Mann-Whitney *U*=190.0, *p*=0.799).

The two measures used to assess neurocognitive functioning in the study had different results. The results for the LNST, which assesses verbal working memory, were similar in the two groups at baseline, improved slightly over the 6-week trial in both groups, and remained similar between groups at the end of the trial. Results for the HKLLT, which assesses verbal learning and memory, indicated that the intervention group had significantly poorer verbal learning skills than the control group at baseline and that these skills got significantly worse over the 6-week intervention. However, verbal learning also deteriorated in the control group over the 6-week trial, so after adjusting for baseline values the difference between groups in verbal learning at the end of the trial was no longer statistically significant.

4.2. Results of facial emotion recognition tests {#s9b}
================================================

Results of the facial emotion recognition tests are shown in [Table 3](#Table3){ref-type="table"}. Neither the total recognition score nor any of the 6 sub-scores were significantly different at baseline between the two groups. In the intervention group there was a significant improvement in the total score over the 6-week intervention, but after adjusting for baseline values the difference between the intervention group and control group at the end of the trial was not statistically significant (though there was a trend \[*p*=0.09\] in favor of the intervention group). Among the six sub-scores, both the recognition of sad faces and of fearful faces improved substantially in the intervention group (effect size \>0.50), but when compared with the change in the control group, the only statistically significant improvement was in the recognition of fearful faces.

###### 

Table 3. Result of the facial emotion recognition tests before and after the 6-week trial in the intervention and control groups

Table 3

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  characteristic                                                                                                         time                       intervention\        control\         group\
                                                                                                                                                    group\               group\           comparison*^a^*
                                                                                                                                                    (n=20)               (n=20)           
  ---------------------------------------------------------------------------------------------------------------------- -------------------------- -------------------- ---------------- -----------------------------------
  emotional recognition:\                                                                                                baseline, mean (sd)\       10.95 (3.33)\        12.40 (2.68)\    *F*~(1,\ 38)~=2.29; *p*=0.131\
  overall score                                                                                                          6 weeks, mean (sd)\        13.65 (3.39)\        12.25 (3.10)\    *F*~(1,\ 37)~=2.93; *p*=0.092\
                                                                                                                         paired t-test (p-value)\   **-2.60 (0.018)**\   0.24 (0.818)\    \
                                                                                                                         effect size                0.58                 0.05             

  angry faces:\                                                                                                          baseline, mean (sd)\       1.40 (0.82)\         1.35 (1.09)\     *F*~(1,\ 38)~=0.03; *p*=0.871\
  number correct                                                                                                         6 weeks, mean (sd)\        1.70 (1.21)\         1.20 (1.23)\     *F*~(1,\ 37)~=1.66;*p*=0.206\
                                                                                                                         paired t-test (p-value)\   -1.03 (0.316)\       0.53 (0.603)\    \
                                                                                                                         effect size                0.23                 0.11             

  joyful faces:\                                                                                                         baseline, mean (sd)\       3.25 (1.06)\         3.40 (0.94)\     *F*~(1,\ 38)~=0.22; *p*=0.640\
  number correct                                                                                                         6 weeks, mean (sd)\        3.30 (0.73)\         3.30 (0.73)\     *F*~(1,\ 37)~=0.00; *p*=1.000\
                                                                                                                         paired t-test (p-value)\   -0.25 (0.804)\       0.44 (0.666)\    \
                                                                                                                         effect size                0.05                 0.09             

  sad faces:\                                                                                                            baseline, mean (sd)\       1.85 (1.26)\         2.25 (0.91)\     *F*~(1,\ 38)~=1.31; *p*=0.259\
  number correct                                                                                                         6 weeks, mean (sd)\        2.90 (1.02)\         2.40 (0.99)\     *F*~(1,\ 38)~=1.88; *p*=0.125
                                                                                                                         paired t-test (p-value)\   **-2.30 (0.033)**\   -0.68 (0.505)\   
                                                                                                                         effect size                0.51                 0.15             

  surprised faces:\                                                                                                      baseline, mean (sd)\       1.85 (0.98)\         2.35 (1.22)\     *F*~(1,\ 38)~=2.01; *p*=0.164\
  number correct                                                                                                         6 weeks, mean (sd)\        2.20 (1.00)\         2.35 (1.18)\     *F*~(1,\ 37)~=0.18; *p*=0.668
                                                                                                                         paired t-test (p-value)\   -1.07 (0.297)\       0.00 (1.000)\    
                                                                                                                         effect size                0.24                 0.00             

  fearful faces:\                                                                                                        baseline, mean (sd)\       0.65 (0.74)\         0.70 (0.65)\     *F*~(1,\ 38)~=0.05; *p*=0.823\
  number correct                                                                                                         6 weeks, mean (sd)\        1.50 (1.14)\         0.85 (0.67)\     ***F*~(1,\ 37)~=5.13; *p*=0.027**
                                                                                                                         paired t-test (p-value)\   **-2.82 (0.011)**\   -1.14 (0.267)\   
                                                                                                                         effect size                0.63                 0.25             

  disgust-expressing faces:\                                                                                             baseline, mean (sd)\       1.95 (1.19)\         2.35 (1.08)\     *F*~(1,\ 38)~=1.22; *p*=0.275\
  number correct                                                                                                         6 weeks, mean (sd)\        2.05 (0.68)\         2.15 (1.18)\     *F*~(1,\ 37)~=0.10; *p*=0.745
                                                                                                                         paired t-test (p-value)\   -0.36 (0.725)\       0.72 (0.478)\    
                                                                                                                         effect size                0.08                 0.16             

  ^a^ The F-value at 6 weeks is for an analysis of covariance (ANCOVA) that uses the result at baseline as a covariate                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

4.3. Changes in cognitive scores and emotional recognition scores during the 12 training sessions in the intervention group {#s9c}
===========================================================================================================================

[Figure 2](#Figure2){ref-type="fig"} displays the mean performances for the intervention group across the 12 training sessions on the five cognitive drill training tasks. Comparison of the mean (sd) score in the 12th session with that in the 1st session using paired t-tests had the following results: pair matching (*t*=-4.53, *p* \< 0.001) ; arithmetic (*t*=0.25, *p*=0.805), number list (*t*=-1.27, *p*=0.227), spatial working memory (*t*=0.47, *p*=0.647), and word lists (*t*=-0.33, *p*=0.198). [Figure 3](#Figure3){ref-type="fig"} displays the mean performance (i.e., number of correctly identified faces) for the intervention group for each of the six different types of facial expressions in the FAR test over the 12 training sessions. Comparison of the mean number of correct responses in the 1^st^ session with that in the 12^th^ session, did not indicate significant improvement in the recognition of any of the six emotions. The mean (sd) total number of correct identifications in trial 1 was 10.5 (1.9) compared to 10.9 (2.7) in trial 12 (paired *t*=-0.69, *p*=0.495).

![Figure 2. Mean performance on cognitive skills during the 12 training sessions conducted over 6 weeks in the intervention group (n=20)](sap-27-05-296-g003){#Figure2}

![Figure 3. Mean performance on facial affect recognition test during the 12 training sessions conducted over 6 weeks in the intervention group (n=20)](sap-27-05-296-g004){#Figure3}

5.. Discussion {#s10}
==============

5.1. Main findings {#s10a}
==================

The current study was designed to replicate our previous research using a simple user-friendly, computer based drill training program that could be applied in a relative short time period in different cross-cultural settings to enhance the performance of individuals with schizophrenia on tasks of memory, attention, and social functioning. We failed to replicate the gains that we found previously in an inpatient sample, \[[@B19]\] and we were unable to replicate the research of others who have used more sophisticated interventions\[[@B16]\] to improve attention and working memory. In fact, the intervention group performed significantly worse on a measure of verbal memory after the intervention than at baseline. Four of the five specific skills repeatedly practiced by individuals in the intervention group failed to show any improvement during the 12 training sessions over 6 weeks. This was a surprising finding given our prior study and the now substantial evidence for the effectiveness of cognitive remediation in schizophrenia. We speculate that there may be cohort-specific issues at play that resulted in the largely null findings. A recent paper\[[@B35]\] suggests that intrinsic motivation mediates the relationship between neurocognition and functional outcomes and that both the instructional method and the motivation of participants is important. It is possible that the current group lacked motivation to pay sufficient attention to the training tasks during the intervention.

The intervention group showed small but measurable improvements on the Personal and Social Performance (PSP) scale, a measure of social functioning. Although the improvements were not enough to improve the classification range for the group (most intervention group participants remained in the 'disabled' range), it does give tentative support to the notion that involvement in remediation programs can have a positive effect on social functioning. Medalia's recent review\[[@B36]\] concluded that cognitive remediation has the greatest effect on social functioning when it is part of an comprehensive psychosocial rehabilitation program, as was the case in this study. The rehabilitation program at the Shanghai Mental Health Center in which intervention group patients participated in has been shown to be effective in improving psychosocial outcomes for participants, \[[@B37]\] so this may have contributed to the modest improvement in social functioning seen over the 6 weeks of the current study.

In our previous study we also found significant improvements in the PANSS scores of the intervention group.\[[@B19]\] This finding was replicated here, but the improvements were modest and not significantly greater than those seen in the control group. Engagement in a relatively intensive remediation program may have a positive impact on symptomatology .

This study added a facial emotion recognition component to the training sessions that was not included in the previous study. Over the 12 training sessions the recognition of facial emotions by individuals in the intervention group did not improve significantly for any of the six facial emotions, but the pre-post change in the FAR test (which used different faces than used in the training sessions) did show a statistically significant improvement in the overall emotional recognition rate in the intervention group and a statistical trend of a greater improvement in the intervention group than in the control group (*p*=0.09). Considering recognition of the six specific emotions, only the recognition of fear and sadness substantially improved over the six weeks of training in the intervention group (effect size \>0.50), and only the recognition of fearful faces improved significantly more in the intervention group than in the control group. This may be related to the finding that the recognition of negative emotions of fear, sadness and disgust have been found to be differentially more impaired than the recognition of other emotions in individuals with schizophrenia\[[@B38], [@B39], [@B40], [@B41]\] and in relatives of people with schizophrenia.\[[@B42]\]

5.2. Limitations {#s10b}
================

There are several limitations to this study that will need to be addressed in future studies. a) The sample size was relatively small (although comparable to other studies utilizing drill and practice training\[[@B43], [@B44], [@B45]\]) so some of the negative findings may have been due to Type II errors. b) The sample was limited to males who were currently using antipsychotic medications and being treated at a single specialized psychiatric hospital. It is unclear how generalizable the results are to other individuals with schizophrenia. c) Assignment to the intervention and control group was not randomized; all intervention group subjects were currently participating in a rehabilitation program while all control group subjects were not. d) The clinicians who assessed outcomes were not blind to the group assignment of the patients they were evaluating. e) The photographs used in training and testing of FAR were limited to individuals 20-29 years of age. Whether or not the ability to recognize the facial emotions of individuals in these ages is representative of the ability to recognize the facial emotions of individuals at other ages (whom individuals with schizophrenia frequently need to interact with) is unknown. f) The test-retest reliability and other psychometric measures of the outcome variable used to assess the effectiveness of FAR training (the number of correctly identified facial emotions) has never been tested so the validity of this measure remains unknown. g) No adjustment was made for the IQ of participants. h) A single measure was used to assess social functioning; a more comprehensive assessment will be needed to confirm the finding of improved social functioning with the remediation training. i) Several of the remediation training tasks were aimed at spatial working memory but this was not assessed before and after the intervention.

5.3. Importance {#s10c}
===============

The results of this study highlight the fact that to be effective cognitive remediation for individuals with schizophrenia needs to be conducted in a specific type of setting in which participants are actively engaged in the process. This study is one of the first attempts to integrate FAR training as part of a short, computer administrated cognitive remediation program in China. The results suggest (but do not prove) that this type of training could improve overall recognition of facial emotions (particularly fear) by individuals with schizophrenia, but more work on developing the content, duration, and frequency of the training and on testing the resultant training modules in larger, more diverse samples will be needed before this can be recommended as a standard part of cognitive remediation programs.
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